6.32  0.87 (15.96%)		02-23 16:00
Open: 5.21 High: 6.32 Volume: 271,721		Pre. Close: 5.45 Low: 5.18 Market Cap: 166(M)

Short term
Mid term
Targets	6-month :	7.38	1-year :	8.62
Resists	First :	6.32	Second :	7.38
Pivot price	5.3
Supports	First :	4.82	Second :	3.9
MAs	MA(5) :	5.49	MA(20) :	5.07
	MA(100) :	4.25	MA(250) :	2.54
MACD	MACD :	0.3	Signal :	0.2
%K %D	K(14,3) :	87.2	D(3) :	81.4
RSI	RSI(14): 75.3
52-week	High :	6.32	Low :	0.97

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IMRA ] has closed Bollinger Bands are 9.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	6.32 - 6.34	6.34 - 6.36
Low:	5.13 - 5.15	5.15 - 5.17
Close:	6.27 - 6.31	6.31 - 6.35

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Tue, 06 Feb 2024
Imran Khan moved out of bungalow, sold Ferrari and left films to fix himself - Hindustan Times

Tue, 09 Jan 2024
Imran Khan poses with rumoured GF Lekha & daughter Imara at Ira Khan's Mehendi; picture goes viral - The Times of India

Tue, 09 Jan 2024
Imran Khan, mom Nuzhat, daughter Imara, rumoured girlfriend Lekha Washington feature in family portrait at Ira Khan-Nupur Shikhare’s mehendi. See - The Indian Express

Wed, 22 Feb 2023
Imara Announces Stockholder Approval of Merger With Enliven - GlobeNewswire

Fri, 06 Jan 2023
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch - Penny Stocks

Mon, 17 Oct 2022
Imara Inc (IMRA) has fallen 1.06% Monday In Premarket Trading - InvestorsObserver

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	26 (M)
Shares Float	9 (M)
Held by Insiders	16.6 (%)
Held by Institutions	71.3 (%)
Shares Short	341 (K)
Shares Short P.Month	1,370 (K)

EPS	-2.5
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.77
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-34.2 %
Return on Equity (ttm)	-57.5 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.71
Qtrly Earnings Growth	0 %
Operating Cash Flow	-46 (M)
Levered Free Cash Flow	-30 (M)

PE Ratio	-2.54
PEG Ratio	0
Price to Book value	1.67
Price to Sales	0
Price to Cash Flow	-3.6

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.